Oxford awarded more than $3M for cancer imaging

TriMed Staff | | Health Imaging | Diagnostic Imaging
Cancer Research UK, the Engineering and Physical Sciences Research Council (EPSRC) and the Medical Research Council (MRC), has awarded the University of Oxford £2 million ($3.49 million U.S.), as part of a nationwide, five-year investment in cancer imaging.

The university said that the money will be used to develop cancer imaging technologies, such as MRI and PET, as well as equipment to allow scientists to watch cells in action by tracing radioactive biomarkers injected into patients, the BBC reported.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.